Strategy’s $216 million Bitcoin sale on Monday should be seen as a positive development for the price of Bitcoin and as a move that renews confidence in STRC, according to analysts.The sale of 3,588 BTC to fund preferred stock dividend payments and replenish cash has boosted Strategy’s dollar reserves to cover 17 months of dividend payments. “The rebound in STRC suggests investors are responding positively to this decision,” Grayscale Research said Monday.Andri Fauzan Adziima, research lead at Bitrue Research Institute, told Cointelegraph that Strategy’s recent sale was a “smart, stabilizing move that actually strengthens the setup for Bitcoin.”Zach Pandl, Grayscale’s…

Science does not often advance in sudden epiphanies that yield “Eureka” moments. More typical are years of failed experiments, dogged hypothesis-testing, and incremental discoveries that are, at best, inconclusive. And then, sometimes, eventually, the accumulated knowledge results in a breakthrough. Two recent examples are stunning advances in cancer medicine—one for pancreatic cancer, the other for melanoma—that are rewriting what doctors can promise their patients. But to understand why these achievements matter so profoundly, it is instructive to appreciate how long they took.A Pill That Doubled Survival for the Disease That Kills Almost EveryonePancreatic cancer is the third-leading cause of cancer…

AI & Crypto

Read More

Politics

Don't Miss!